WHO ICTRP trial
Thymol Dressing in Diabetic foot Ulcer
IRCT20170612034485N3 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20170612034485N3 |
|---|---|
| Public title | Thymol Dressing in Diabetic foot Ulcer |
| Scientific title | Evaluation of Safety and Efficacy of Hydropolymer Dressing (Hydrogel) with Thymol for the Treatment of Neuropatic Diabetic Foot Ulcer in a Phase I/II Clinical Trail |
| Primary sponsor | Iranian academic center for education culture and research |
| Secondary sponsors | Atin Biopolymer Products (Joint Stock) |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Chronic neuropathic diabetic foot Ulcer. Type 2 diabetes mellitus with foot ulcer;E11.621 |
| Interventions | Intervention group: in this group, the patients will use thymol-honey (Herbaderm) dressing on their granulated wound daily. the dressing will be changed every 24 hours.. |
| Registration date | Dec 30, 2018 |
| Target size | 20 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: